Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously

Report a female diagnosed as type 1 Gaucher disease after a femoral pathologic fracture when she was 55 years old. Enzyme replacement therapy was started, and she achieved therapeutic goals. In 2015, a Ph’ CML with numerous pseudo‐Gaucher cells in bone marrow appears. BCR/ABL was not present at GD d...

Descripción completa

Detalles Bibliográficos
Autores principales: Noya, MSoledad, Andrade‐Campos, Marcio, Irun, Pilar, López de Frutos, Laura, López‐Fernandez, MFernanda, Giraldo, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930224/
https://www.ncbi.nlm.nih.gov/pubmed/29744080
http://dx.doi.org/10.1002/ccr3.1460
_version_ 1783319465377660928
author Noya, MSoledad
Andrade‐Campos, Marcio
Irun, Pilar
López de Frutos, Laura
López‐Fernandez, MFernanda
Giraldo, Pilar
author_facet Noya, MSoledad
Andrade‐Campos, Marcio
Irun, Pilar
López de Frutos, Laura
López‐Fernandez, MFernanda
Giraldo, Pilar
author_sort Noya, MSoledad
collection PubMed
description Report a female diagnosed as type 1 Gaucher disease after a femoral pathologic fracture when she was 55 years old. Enzyme replacement therapy was started, and she achieved therapeutic goals. In 2015, a Ph’ CML with numerous pseudo‐Gaucher cells in bone marrow appears. BCR/ABL was not present at GD diagnosis.
format Online
Article
Text
id pubmed-5930224
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-59302242018-05-09 Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously Noya, MSoledad Andrade‐Campos, Marcio Irun, Pilar López de Frutos, Laura López‐Fernandez, MFernanda Giraldo, Pilar Clin Case Rep Case Reports Report a female diagnosed as type 1 Gaucher disease after a femoral pathologic fracture when she was 55 years old. Enzyme replacement therapy was started, and she achieved therapeutic goals. In 2015, a Ph’ CML with numerous pseudo‐Gaucher cells in bone marrow appears. BCR/ABL was not present at GD diagnosis. John Wiley and Sons Inc. 2018-03-15 /pmc/articles/PMC5930224/ /pubmed/29744080 http://dx.doi.org/10.1002/ccr3.1460 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Noya, MSoledad
Andrade‐Campos, Marcio
Irun, Pilar
López de Frutos, Laura
López‐Fernandez, MFernanda
Giraldo, Pilar
Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously
title Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously
title_full Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously
title_fullStr Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously
title_full_unstemmed Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously
title_short Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously
title_sort gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930224/
https://www.ncbi.nlm.nih.gov/pubmed/29744080
http://dx.doi.org/10.1002/ccr3.1460
work_keys_str_mv AT noyamsoledad gaucherdiseaseandchronicmyeloidleukemiafirstreportedpatientreceivingenzymereplacementandtyrosinekinaseinhibitortherapiessimultaneously
AT andradecamposmarcio gaucherdiseaseandchronicmyeloidleukemiafirstreportedpatientreceivingenzymereplacementandtyrosinekinaseinhibitortherapiessimultaneously
AT irunpilar gaucherdiseaseandchronicmyeloidleukemiafirstreportedpatientreceivingenzymereplacementandtyrosinekinaseinhibitortherapiessimultaneously
AT lopezdefrutoslaura gaucherdiseaseandchronicmyeloidleukemiafirstreportedpatientreceivingenzymereplacementandtyrosinekinaseinhibitortherapiessimultaneously
AT lopezfernandezmfernanda gaucherdiseaseandchronicmyeloidleukemiafirstreportedpatientreceivingenzymereplacementandtyrosinekinaseinhibitortherapiessimultaneously
AT giraldopilar gaucherdiseaseandchronicmyeloidleukemiafirstreportedpatientreceivingenzymereplacementandtyrosinekinaseinhibitortherapiessimultaneously

Ejemplares similares